However, the subsequent bacterial increase following long term treatment with IVA indicates a negative impact of CFTR modulators on the lung microbiome; increasing susceptibility to infection and posing the question, can the bacteria deploy similar strategies to antimicrobial resistance to protect themselves from killing by CFTR modulators? The gene discussed is CFTR; the disease is infection.